Literature DB >> 9261426

Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.

L Berthoux1, C Péchoux, M Ottmann, G Morel, J L Darlix.   

Abstract

Nucleocapsid protein NCp7 of human immunodeficiency virus type 1 (HIV-1) is a small basic nucleic acid binding protein containing two zinc fingers of the form (CX2CX4HX4C) and is present at about 2,000 copies inside the viral core. NCp7 molecules are tightly associated with the genomic RNA dimer to form the nucleocapsid, which also includes reverse transcriptase and integrase proteins. In vitro, NCp7 has been shown to bind specifically to HIV-1 RNA, inducing NCp7-NCp7 interactions. In the viral context, mutagenesis of amino acid residues in the zinc finger domains showed that NCp7 is responsible for the specific incorporation of genomic RNA into virions and is necessary for correct virion assembly and maturation. In this work, we investigated the consequences of mutating conserved basic residues in the N-terminal region that precedes the first zinc finger. Two of the mutants were poorly infectious and showed only limited, though significant, defects in RNA encapsidation and viral protein maturation. Electron microscopy, together with sucrose gradient analysis, revealed defects in particle core structure and heterogeneity among mutant virions. These defects were associated with strong reduction of proviral DNA synthesis and stability in newly infected cells. Taken together, these data show multiple and probably interdependent implications for the NCp7 protein in both early and late phases of the HIV-1 replicative cycle and emphasize it as a target for antiviral drug development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261426      PMCID: PMC191982     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  High efficiency gene transfer into mammalian cells by a double transfection protocol.

Authors:  Y Ishikawa; C J Homcy
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

2.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers.

Authors:  H De Rocquigny; C Gabus; A Vincent; M C Fournié-Zaluski; B Roques; J L Darlix
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

4.  Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.

Authors:  R J Gorelick; S M Nigida; J W Bess; L O Arthur; L E Henderson; A Rein
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

5.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA.

Authors:  R Khan; D P Giedroc
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

7.  Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.

Authors:  J L Darlix; C Gabus; M T Nugeyre; F Clavel; F Barré-Sinoussi
Journal:  J Mol Biol       Date:  1990-12-05       Impact factor: 5.469

8.  Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds.

Authors:  W G Rice; C A Schaeffer; B Harten; F Villinger; T L South; M F Summers; L E Henderson; J W Bess; L O Arthur; J S McDougal
Journal:  Nature       Date:  1993-02-04       Impact factor: 49.962

9.  Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr.

Authors:  V Planelles; F Bachelerie; J B Jowett; A Haislip; Y Xie; P Banooni; T Masuda; I S Chen
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR.

Authors:  N Morellet; N Jullian; H De Rocquigny; B Maigret; J L Darlix; B P Roques
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  33 in total

1.  Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.

Authors:  J Gonsky; E Bacharach; S P Goff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Role of RNA in facilitating Gag/Gag-Pol interaction.

Authors:  Ahmad Khorchid; Rabih Halwani; Mark A Wainberg; Lawrence Kleiman
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  DNA condensation by the nucleocapsid protein of HIV-1: a mechanism ensuring DNA protection.

Authors:  G Krishnamoorthy; Bernard Roques; Jean-Luc Darlix; Yves Mély
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

5.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.

Authors:  L Berthoux; C Péchoux; J L Darlix
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.

Authors:  A Cimarelli; S Sandin; S Höglund; J Luban
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Evolution of feline immunodeficiency virus Gag proteins.

Authors:  Evan Burkala; Mary Poss
Journal:  Virus Genes       Date:  2007-01-30       Impact factor: 2.332

Review 9.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

10.  The yeast Ty3 retrotransposon contains a 5'-3' bipartite primer-binding site and encodes nucleocapsid protein NCp9 functionally homologous to HIV-1 NCp7.

Authors:  C Gabus; D Ficheux; M Rau; G Keith; S Sandmeyer; J L Darlix
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.